Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

WPX Energy Posts Loss In Q4 - Quick Facts

RELATED NEWS
Trade WPX now with 

WPX Energy (WPX: Quote) posted fourth-quarter loss of $338 million or $1.72 per share versus a profit of $12 million or $0.06 per share last year.

WPX results were impacted by non-cash impairment charges during the fourth quarter primarily due to a decline in forward natural gas prices.

On average, three analysts polled by Thomson Reuters expected the company to report earnings of $0.19 per share. Analysts' estimates typically exclude special items.

Total revenues grew to $992 million from $960 million in the prior-year quarter.

Click here to receive FREE breaking news email alerts for WPX Energy and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Following the long, holiday weekend, stocks may move to the upside in early trading on Tuesday. The major index futures are currently pointing to a modestly higher open for the markets, with the Dow futures up by 15 points. The Swiss economy stalled in the second quarter as the improvement in household spending was insufficient to offset the weakness in exports and investment in construction. Gross domestic product remained flat from the first quarter, when it accelerated to 0.5 percent, the State Secretariat for Economic Affairs said Tuesday. Economists had expected GDP to rise 0.5 percent in the second quarter. Policymakers of Reserve Bank of Australia decided to maintain its record low interest rate once again as they continue to assess that the most prudent course is a period of stability in interest rates. The monetary policy board retained the cash rate at 2.50 percent. The rate has been at the current level since August 2013.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.